特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
934758

プロテオミクスの世界市場:2025年までの用途別、適応症別、技術別、タイプ別、 製品別、エンドユーザー別、地域別の競合、予測、機会

Global Proteomics Market By Application, By Indication, By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 115 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.89円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

プロテオミクスの世界市場:2025年までの用途別、適応症別、技術別、タイプ別、 製品別、エンドユーザー別、地域別の競合、予測、機会
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 115 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界のプロテオミクス市場を調査したもので、各地域市場の展 望、市場の力学、主なトレンド、競合情勢などの情報を提供するとともに、戦略的 提言を示しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のプロテオミクス市場展望

  • 市場規模と予測
  • 市場シェアと予測
    • 用途別(創薬、診断バイオマーカー発見、臨床診断、その他)
    • 適応症別(感染症、循環器、神経血管、糖尿病、その他)
    • 技術別
    • タイプ別(機能、表現、構造、計算)
    • 製品別(ソフトウェア、機器、試薬およびアッセイ、サービス)
    • エンドユーザー別(製薬およびバイオテクノロジー企業、 調査機関、CRO)
    • 会社別(2019)
    • 地域別
  • 市場魅力指数

第5章 アジア太平洋のプロテオミクス市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 用途別
    • 適応症別
    • 技術別
    • タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • アジア太平洋地域:国分析
    • 中国プロテオミクス市場の展望
    • インドのプロテオミクス市場の展望
    • 日本のプロテオミクス市場の展望
    • 韓国のプロテオミクス市場の展望
    • シンガポールのプロテオミクス市場の展望
    • オーストラリアのプロテオミクス市場の展望

第6章 欧州のプロテオミクス市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 用途別
    • 適応症別
    • 技術別
    • タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 欧州:国分析
    • フランスのプロテオミクス市場の展望
    • ドイツのプロテオミクス市場の展望
    • 英国のプロテオミクス市場の展望
    • イタリアのプロテオミクス市場の展望

第7章 北米のプロテオミクス市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 用途別
    • 適応症別
    • 技術別
    • タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 北米:国分析
    • 米国プロテオミクス市場の展望
    • メキシコのプロテオミクス市場の展望
    • カナダのプロテオミクス市場の展望

第8章 南米のプロテオミクス市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 用途別
    • 適応症別
    • 技術別
    • タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 南米:国分析
    • ブラジルのプロテオミクス市場の展望
    • アルゼンチンのプロテオミクス市場の展望
    • コロンビアのプロテオミクス市場の展望

第9章 中東とアフリカのプロテオミクス市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 用途別
    • 適応症別
    • 技術別
    • タイプ別
    • 製品別
    • エンドユーザー別
    • 国別
  • 市場魅力指数
  • 中東・アフリカ地域:国分析
    • 南アフリカのプロテオミクス市場の展望
    • サウジアラビアプロテオミクス市場の展望
    • UAEプロテオミクス市場の展望

第10章 市場力学

  • 促進要因
  • 課題

第11章 市場動向

第12章 競合情勢

  • 競合の展望
  • 主要企業のプロファイル
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Waters Corporation
    • Bio-Rad Laboratories
    • GE Healthcare
    • PerkinElmer
    • Creative Proteomics
    • Luminex Corporation
    • Promega Corporation
    • Caprion
    • Bruker
    • Pfizer
    • Horiba
    • Qiagen
    • Becton Dickinson
    • Bioproximity
    • Biocon
    • Evotec
    • Bristol-Myers Squibb
    • Illumina
    • Takeda Pharmaceuticals

第13章 戦略的提言

第14章 免責事項

目次
Product Code: 4559

Global proteomics market is expected to grow at a brisk CAGR during the forecast period. The key factor responsible for increased demand for proteomics is due to growing investments in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, increasing demand for personalized medicine is anticipated to bode well for the growth of proteomics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2025.

The global proteomics market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into drug discovery, diagnostic biomarker discovery, clinical diagnostic, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem MS and LC are some proteomics technology that are effective for the identification of proteins, thus boosting the growth of the segment across the globe.

Major players operating in the global proteomics market include Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bio-Rad Laboratories, GE Healthcare, PerkinElmer, Creative Proteomics, Luminex Corporation, Promega Corporation, Caprion, Bruker, Pfizer, Horiba, Qiagen, Becton Dickinson, Bioproximity, Biocon, Evotec, Bristol-Myers Squibb, Illumina, Takeda Pharmaceuticals, etc. The companies operating in proteomics market across the globe are focussing more towards the expanding their share in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global proteomics market.
  • To classify and forecast global proteomics market based on application, indication, technology, type, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global proteomics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global proteomics market.
  • To conduct pricing analysis for global proteomics market.
  • To identify and analyse the profile of leading players operating in global proteomics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global proteomics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Proteomics companies, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to proteomics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global proteomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Application:

Drug Discovery

Diagnostic Biomarker Discovery

Clinical diagnostic

Others

  • Market, By Indication:

Infectious Disease

Cardiology

Neurovascular

Diabetes

Others

  • Market, By Technology:

Conventional

  • Chromatography
  • ELISA
  • Western blotting

Advanced

  • Protein microarray
  • Gel electrophoresis
  • Mass Spectrophotometry
  • Edman Sequencing

Quantitative

  • Isotope-coded affinity tag labelling
  • Stable isotope labelling with amino acids in cell culture
  • Isobaric tag for relative and absolute quantitation

High-thoroughput

  • X-ray crystallography
  • NMR

Bioinformatic analysis

  • Market, By Type:

Functional

Expression

Structural

Computational

  • Market, By Product:

Software

Instruments

Reagents and Assays

Services

  • Market, By End-User:

Pharmaceutical and biotechnology companies

Research institutes

CROs

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global proteomics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Proteomics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Application (Drug Discovery, Diagnostic Biomarker Discovery, Clinical diagnostic, Others)
    • 4.2.2. By Indication (Infectious Disease, Cardiology, Neurovascular, Diabetes, Others)
    • 4.2.3. By Technology
        • 4.2.3.1.1. Conventional (Chromatography (HPLC, Affinity, Others), ELISA, Western blotting)
        • 4.2.3.1.2. Advanced (Protein microarray (Analytical, Functional, Reverse-phase), Gel electrophoresis (2D, Capillary, SDS-PAGE, 2D-DIGE), Mass Spectrophotometry, Edman Sequencing)
        • 4.2.3.1.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
        • 4.2.3.1.4. High-thoroughput (X-ray crystallography, NMR)
        • 4.2.3.1.5. Bioinformatic analysis
    • 4.2.4. By Type (Functional, Expression, Structural, Computational)
    • 4.2.5. By Product (Software, Instruments, Reagents and Assays, Services)
    • 4.2.6. By End-User (Pharmaceutical and biotechnology companies, Research institutes, CROs)
    • 4.2.7. By Company (2019)
    • 4.2.8. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Proteomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application
    • 5.2.2. By Indication
    • 5.2.3. By Technology
    • 5.2.4. By Type
    • 5.2.5. By Product
    • 5.2.6. By End-User
    • 5.2.7. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Proteomics Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Application
        • 5.4.1.2.2. By Indication
        • 5.4.1.2.3. By Technology
        • 5.4.1.2.4. By Type
        • 5.4.1.2.5. By Product
        • 5.4.1.2.6. By End-User
    • 5.4.2. India Proteomics Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Application
        • 5.4.2.2.2. By Indication
        • 5.4.2.2.3. By Technology
        • 5.4.2.2.4. By Type
        • 5.4.2.2.5. By Product
        • 5.4.2.2.6. By End-User
    • 5.4.3. Japan Proteomics Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Application
        • 5.4.3.2.2. By Indication
        • 5.4.3.2.3. By Technology
        • 5.4.3.2.4. By Type
        • 5.4.3.2.5. By Product
        • 5.4.3.2.6. By End-User
    • 5.4.4. South Korea Proteomics Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Application
        • 5.4.4.2.2. By Indication
        • 5.4.4.2.3. By Technology
        • 5.4.4.2.4. By Type
        • 5.4.4.2.5. By Product
        • 5.4.4.2.6. By End-User
    • 5.4.5. Singapore Proteomics Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Application
        • 5.4.5.2.2. By Indication
        • 5.4.5.2.3. By Technology
        • 5.4.5.2.4. By Type
        • 5.4.5.2.5. By Product
        • 5.4.5.2.6. By End-User
    • 5.4.6. Australia Proteomics Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Application
        • 5.4.6.2.2. By Indication
        • 5.4.6.2.3. By Technology
        • 5.4.6.2.4. By Type
        • 5.4.6.2.5. By Product
        • 5.4.6.2.6. By End-User

6. Europe Proteomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Indication
    • 6.2.3. By Technology
    • 6.2.4. By Type
    • 6.2.5. By Product
    • 6.2.6. By End-User
    • 6.2.7. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Proteomics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Application
        • 6.4.1.2.2. By Indication
        • 6.4.1.2.3. By Technology
        • 6.4.1.2.4. By Type
        • 6.4.1.2.5. By Product
        • 6.4.1.2.6. By End-User
    • 6.4.2. Germany Proteomics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Application
        • 6.4.2.2.2. By Indication
        • 6.4.2.2.3. By Technology
        • 6.4.2.2.4. By Type
        • 6.4.2.2.5. By Product
        • 6.4.2.2.6. By End-User
    • 6.4.3. United Kingdom Proteomics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Application
        • 6.4.3.2.2. By Indication
        • 6.4.3.2.3. By Technology
        • 6.4.3.2.4. By Type
        • 6.4.3.2.5. By Product
        • 6.4.3.2.6. By End-User
    • 6.4.4. Italy Proteomics Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Application
        • 6.4.4.2.2. By Indication
        • 6.4.4.2.3. By Technology
        • 6.4.4.2.4. By Type
        • 6.4.4.2.5. By Product
        • 6.4.4.2.6. By End-User

7. North America Proteomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Indication
    • 7.2.3. By Technology
    • 7.2.4. By Type
    • 7.2.5. By Product
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Proteomics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Application
        • 7.4.1.2.2. By Indication
        • 7.4.1.2.3. By Technology
        • 7.4.1.2.4. By Type
        • 7.4.1.2.5. By Product
        • 7.4.1.2.6. By End-User
    • 7.4.2. Mexico Proteomics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Application
        • 7.4.2.2.2. By Indication
        • 7.4.2.2.3. By Technology
        • 7.4.2.2.4. By Type
        • 7.4.2.2.5. By Product
        • 7.4.2.2.6. By End-User
    • 7.4.3. Canada Proteomics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Application
        • 7.4.3.2.2. By Indication
        • 7.4.3.2.3. By Technology
        • 7.4.3.2.4. By Type
        • 7.4.3.2.5. By Product
        • 7.4.3.2.6. By End-User

8. South America Proteomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Indication
    • 8.2.3. By Technology
    • 8.2.4. By Type
    • 8.2.5. By Product
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Proteomics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Application
        • 8.4.1.2.2. By Indication
        • 8.4.1.2.3. By Technology
        • 8.4.1.2.4. By Type
        • 8.4.1.2.5. By Product
        • 8.4.1.2.6. By End-User
    • 8.4.2. Argentina Proteomics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Application
        • 8.4.2.2.2. By Indication
        • 8.4.2.2.3. By Technology
        • 8.4.2.2.4. By Type
        • 8.4.2.2.5. By Product
        • 8.4.2.2.6. By End-User
    • 8.4.3. Colombia Proteomics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Application
        • 8.4.3.2.2. By Indication
        • 8.4.3.2.3. By Technology
        • 8.4.3.2.4. By Type
        • 8.4.3.2.5. By Product
        • 8.4.3.2.6. By End-User

9. Middle East and Africa Proteomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Indication
    • 9.2.3. By Technology
    • 9.2.4. By Type
    • 9.2.5. By Product
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Proteomics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Application
        • 9.4.1.2.2. By Indication
        • 9.4.1.2.3. By Technology
        • 9.4.1.2.4. By Type
        • 9.4.1.2.5. By Product
        • 9.4.1.2.6. By End-User
    • 9.4.2. Saudi Arabia Proteomics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Application
        • 9.4.2.2.2. By Indication
        • 9.4.2.2.3. By Technology
        • 9.4.2.2.4. By Type
        • 9.4.2.2.5. By Product
        • 9.4.2.2.6. By End-User
    • 9.4.3. UAE Proteomics Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Application
        • 9.4.3.2.2. By Indication
        • 9.4.3.2.3. By Technology
        • 9.4.3.2.4. By Type
        • 9.4.3.2.5. By Product
        • 9.4.3.2.6. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. Thermo Fisher Scientific
    • 12.2.2. Agilent Technologies
    • 12.2.3. Waters Corporation
    • 12.2.4. Bio-Rad Laboratories
    • 12.2.5. GE Healthcare
    • 12.2.6. PerkinElmer
    • 12.2.7. Creative Proteomics
    • 12.2.8. Luminex Corporation
    • 12.2.9. Promega Corporation
    • 12.2.10. Caprion
    • 12.2.11. Bruker
    • 12.2.12. Pfizer
    • 12.2.13. Horiba
    • 12.2.14. Qiagen
    • 12.2.15. Becton Dickinson
    • 12.2.16. Bioproximity
    • 12.2.17. Biocon
    • 12.2.18. Evotec
    • 12.2.19. Bristol-Myers Squibb
    • 12.2.20. Illumina
    • 12.2.21. Takeda Pharmaceuticals

13. Strategic Recommendations

14. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.